Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.
2.

Structural neuroimaging in psychosis: a systematic review and economic evaluation.

Albon E, Tsourapas A, Frew E, Davenport C, Oyebode F, Bayliss S, Arvanitis T, Meads C.

Health Technol Assess. 2008 May;12(18):iii-iv, ix-163. Review.

3.
4.

Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.

Meads C, Auguste P, Davenport C, Małysiak S, Sundar S, Kowalska M, Zapalska A, Guest P, Thangaratinam S, Martin-Hirsch P, Borowiack E, Barton P, Roberts T, Khan K.

Health Technol Assess. 2013 Mar;17(12):1-323. doi: 10.3310/hta17120. Review.

5.

What is the best imaging strategy for acute stroke?

Wardlaw JM, Keir SL, Seymour J, Lewis S, Sandercock PA, Dennis MS, Cairns J.

Health Technol Assess. 2004 Jan;8(1):iii, ix-x, 1-180. Review.

6.

Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.

de Rooij M, Crienen S, Witjes JA, Barentsz JO, Rovers MM, Grutters JP.

Eur Urol. 2014 Sep;66(3):430-6. doi: 10.1016/j.eururo.2013.12.012. Epub 2013 Dec 21.

PMID:
24377803
7.
8.

A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease.

Collins R, Cranny G, Burch J, Aguiar-Ibáñez R, Craig D, Wright K, Berry E, Gough M, Kleijnen J, Westwood M.

Health Technol Assess. 2007 May;11(20):iii-iv, xi-xiii, 1-184. Review.

9.

Noninvasive imaging for the diagnosis of coronary artery disease: focusing the development of new diagnostic technology.

Hunink MG, Kuntz KM, Fleischmann KE, Brady TJ.

Ann Intern Med. 1999 Nov 2;131(9):673-80.

PMID:
10577330
10.
11.

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.

12.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

13.

The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2014 Feb 1;14(1):1-64. eCollection 2014. Review.

14.

Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.

Auguste P, Barton P, Meads C, Davenport C, Małysiak S, Kowalska M, Zapalska A, Guest P, Martin-Hirsch P, Borowiack E, Khan K, Sundar S, Roberts T.

BJOG. 2014 Mar;121(4):464-76. doi: 10.1111/1471-0528.12460. Epub 2013 Dec 3.

15.

Modelling the cost effectiveness of antidepressant treatment in primary care.

Revicki DA, Brown RE, Palmer W, Bakish D, Rosser WW, Anton SF, Feeny D.

Pharmacoeconomics. 1995 Dec;8(6):524-40.

PMID:
10160081
16.

The diagnostic and economic yield of neuroimaging in neuro-ophthalmology.

Mehta S, Loevner LA, Mikityansky I, Langlotz C, Ying GS, Tamhankar MA, Shindler KS, Volpe NJ.

J Neuroophthalmol. 2012 Jun;32(2):139-44. doi: 10.1097/WNO.0b013e31824e3753.

PMID:
22510684
17.

Incorporating patient-centered outcomes in the analysis of cost-effectiveness: imaging strategies for renovascular hypertension.

Carlos RC, Axelrod DA, Ellis JH, Abrahamse PH, Fendrick AM.

AJR Am J Roentgenol. 2003 Dec;181(6):1653-61.

PMID:
14627591
18.

Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.

Guadagnolo BA, Punglia RS, Kuntz KM, Mauch PM, Ng AK.

J Clin Oncol. 2006 Sep 1;24(25):4116-22.

PMID:
16943528
19.

An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence.

Auguste P, Barton P, Hyde C, Roberts TE.

Health Technol Assess. 2011 Apr;15(18):iii-iv, 1-54. doi: 10.3310/hta15180. Review.

20.

Diagnosis of Occult Scaphoid Fractures: A Cost-Effectiveness Analysis.

Karl JW, Swart E, Strauch RJ.

J Bone Joint Surg Am. 2015 Nov 18;97(22):1860-8. doi: 10.2106/JBJS.O.00099.

PMID:
26582616

Supplemental Content

Support Center